Altered gut microbiota in patients with small intestinal bacterial overgrowth
- PMID: 36180941
- DOI: 10.1111/jgh.16013
Altered gut microbiota in patients with small intestinal bacterial overgrowth
Abstract
Background and aim: Small intestinal bacterial overgrowth (SIBO) is diagnosed by using quantitative culture of duodenal aspirates and/or a hydrogen breath test. However, few studies have analyzed bacterial microbiota in Japanese patients with SIBO.
Methods: Twenty-four patients with any abdominal symptoms and suspected SIBO were enrolled. Quantitative culture of duodenal aspirates and a glucose hydrogen breath test were performed on the same day. SIBO was diagnosed based on a bacterial count ≥ 103 CFU/mL or a rise in the hydrogen breath level of ≥ 20 ppm. The composition of the duodenal microbiota was analyzed by 16S rRNA gene sequencing.
Results: Small intestinal bacterial overgrowth was diagnosed in 17 of the 24 patients (71%). The positive rates for the hydrogen breath test and quantitative culture of duodenal aspirates were 50% and 62%, respectively. Patients with SIBO showed significantly reduced α-diversity compared with non-SIBO patients, and analysis of β-diversity revealed significantly different distributions between SIBO and non-SIBO patients. In addition, the intestinal microbiome in SIBO patients was characterized by increased relative abundance of Streptococcus and decreased relative abundance of Bacteroides compared with non-SIBO patients.
Conclusions: Duodenal dysbiosis was identified in patients with SIBO and may play a role in the pathophysiology of SIBO.
Keywords: clinical intestinal disorders; intestinal disorders; small bowel.
© 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
References
-
- Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594.
-
- Chen B, Kim JJ, Zhang Y, Du L, Dai N. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. J. Gastroenterol. 2018; 53: 807-818.
-
- Kumar K, Ghoshal UC, Srivastava D, Misra A, Mohindra S. Small intestinal bacterial overgrowth is common both among patients with alcoholic and idiopathic chronic pancreatitis. Pancreatology 2014; 14: 280-283.
-
- Bauer TM, Steinbruckner B, Brinkmann FE et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am. J. Gastroenterol. 2001; 96: 2962-2967.
-
- Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206-211.
MeSH terms
Substances
Grants and funding
- ASKA Pharmaceutical Co., Ltd.
- JP20gm1010008h9904/Japan Agency for Medical Research and Development
- 18K08002/Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan
- 20FC1037/Health and Labor Sciences Research Grants for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan
LinkOut - more resources
Full Text Sources
